Tert-Butyl-DCL
Tert-Butyl-DCL is a PSMA inhibitor. Tert-Butyl-DCL Tert-Butyl-DCL can be used in the research of prostate cancer[1].
Product Specifications
CAS Number
[1025796-31-9]
Product Name Alternative
(OtBu) KuE (OtBu) 2
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
PSMA
Type
Biochemical Assay Reagents
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tert-butyl-dcl.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC(C)(C)OC([C@H](CCCCN)NC(N[C@H](C(OC(C)(C)C)=O)CCC(OC(C)(C)C)=O)=O)=O
Molecular Formula
C24H45N3O7
Molecular Weight
487.63
Precautions
H302, H315, H319, H335
References & Citations
[1]Binzel DW, et al. RNA Nanoparticles Harboring Radioisotopes or Other Imaging Molecules for Spontaneous Tumor Targeting for Early Cancer Diagnosis. RNA Nanomed. 2025 Aug;2 (1) :10.59566/isrnn.2025.0201d.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15248857 1 Vial
Lentiviral mouse Gm11562 shRNA (UAS) - Lentiviral mouse Gm11562 shRNA (UAS, RFP) plasmid
Ask
View Details 